![]() |
Volumn 99, Issue 16, 2002, Pages 10706-10711
|
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
AVIDIN;
BETA GALACTOSIDASE;
GLUCOSE OXIDASE;
HYBRID PROTEIN;
IMMUNOGLOBULIN G;
TRANSFERRIN RECEPTOR;
TRANSFERRIN RECEPTOR AVIDIN FUSION PROTEIN ANTIBODY;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTIBODY SPECIFICITY;
APOPTOSIS;
ARTICLE;
AUTOTRANSPLANTATION;
BLADDER CARCINOMA;
CANCER CELL;
CELL LINEAGE;
CONTROLLED STUDY;
ENDOCYTOSIS;
GLIOSARCOMA;
INTERNALIZATION;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ANIMALS;
ANTIBODIES;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
AVIDIN;
BIOTIN;
CELL DIVISION;
CROSS-LINKING REAGENTS;
DIMERIZATION;
DRUG DELIVERY SYSTEMS;
ENDOCYTOSIS;
FLUORESCEIN-5-ISOTHIOCYANATE;
GLUCOSE OXIDASE;
HUMANS;
IMMUNOCONJUGATES;
IMMUNOGLOBULIN G;
K562 CELLS;
RATS;
RECEPTORS, TRANSFERRIN;
RECOMBINANT FUSION PROTEINS;
TUMOR CELLS, CULTURED;
ANIMALIA;
|
EID: 0036678172
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.162362999 Document Type: Article |
Times cited : (70)
|
References (47)
|